Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus

International Journal of Biological Sciences

Volumn 4, Issue 2, 2008, Pages 111-115

  Xu, Yuan Yong ^a   Yu, Ji Yun ^b   Zhong, Yan Wei ^c   Song, Hong Bin ^a   Liu, Hui Hui ^d   Jia, Lei Li ^a   Li, Shen Long ^a   Xu, Jian Qiu ^e   Li, Qiao ^b,f  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Institute of Clinical Medical Sciences   (China)

^c BEIJING 302 HOSPITAL   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e Maternal and Child Health Care Hospital of Shaanxi Province   (China)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Genetic susceptibility; Hepatitis B virus (HBV); Human leukocyte antigen (HLA); Intrauterine infection; Nested case control study

Indexed keywords

HLA ANTIGEN CLASS 2; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; IMMUNOGLOBULIN;

ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HEPATITIS B VIRUS; HUMAN; INTRAUTERINE INFECTION; NEWBORN; POLYMERASE CHAIN REACTION; BLOOD; CASE CONTROL STUDY; DISEASE TRANSMISSION; GENETIC PREDISPOSITION; GENETICS; HEPATITIS B; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

HEPATITIS B VIRUS;

CASE-CONTROL STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 44849119504     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4.111     Document Type: Article

References (23)

1. Franchis R, Hadengue A, Lau G, et al. Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B, September 14-16, 2002, Geneva, Switzerland. J Hepatol 2003; 39(Suppl 1):1-235.
2. Shiraki K. Perinatal transmission of hepatitis B virus and its prevention. J Gastroenterol Hepatol 2000; 15:11-15.
3. Wang JS, Zhu QR. [Interruption of the transmission of hepatitis B virus from mother to babies]. Zhonghua Gan Zang Bing Za Zhi 2002; 10:308-10.
4. Thio CL, Thomas DL, Karacki P, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol. 2003; 77: 12083-7.
5. Pajot A, Pancré V, Fazilleau N, et al. Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules. Int Immunol. 2004; 16:1275-82.
6. Rapicetta M, Ferrari C, Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol. 2002; 67:454-7.
7. Hui CK, Lau GK. Immune system and hepatitis B virus infection. J Clin Virol. 2005; 34: S44-8.
8. Lin TM, Chen CJ, Wu MM, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989; 9:737-41.
9. Wu YF, Wang LY, Lee TD, et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 2004;72:17-25.
10. Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005; 41:1383-90.
11. Han YN, Yang JL, Zheng SG, et al. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients. World J Gastroenterol 2005; 11:5721-4.
12. Zhu QR, Ge YL, Gu SQ, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) 2005; 118:1604-9.
13. Gu SQ, Zhu QR, Yu H, et al. Relationship between genetic polymorphism of tumor necrosis factor-alpha and susceptibility to intrauterine HBV infection. Zhonghua Gan Zang Bing Za Zhi 2004; 12:538-9.
14. The EASL Jury. Easl international consensus conference on hepatitis B. J Hepatol 2003; 38:533-40.
15. Shirak K. Perinatal transmission of hepatitis B virus and its prevention. J Gastroenterol Hepatol. 2000;15:E11-E15.
16. Meng XQ, Chen HG, Ma YL, et al. Influence of HLA classII molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China. Hepatobiliary Pancreat Dis Int. 2003; 2: 230-3.
17. Jiang YG, Wang YM, Liu TH, et al. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol. 2003; 9: 2221-5.
18. Ahn SH, Han KH, Park JY, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology. 2000; 31: 1371-3.
19. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J Viral Hepat 1997; 4:215-20.
20. Diepolder HM, Jung MC, Keller E, et al. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998; 113: 244-51.
21. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet. 1994; 344: 1194-5.
22. Kazim SN, Wakil SM, Khan LA, et al. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet. 2002; 359:1488-9.
23. Giovanna F, Bortolotti F, Francesco D. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol.2008; 48:335-52.